{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:11:18Z","timestamp":1790964678156,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the National Science Foundation for Young Scholars of China","award":["81500968"],"award-info":[{"award-number":["81500968"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00415-020-09746-y","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T08:02:44Z","timestamp":1581667364000},"page":"1643-1650","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A study of susceptibility-weighted imaging in patients with Wilson disease during the treatment of metal chelator"],"prefix":"10.1007","volume":"267","author":[{"given":"Xiangxue","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun-hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-ling","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yong","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-bang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-ling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"key":"9746_CR1","first-page":"46","volume":"11","author":"X-L Liang","year":"2001","unstructured":"Liang X-L (2001) Hereditary diseases of the nervous system. People's Mil Med Publ House 11:46\u201347","journal-title":"People's Mil Med Publ House"},{"issue":"6","key":"9746_CR2","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1002\/hep.22261","volume":"47","author":"EA Roberts","year":"2008","unstructured":"Roberts EA, Schilsky ML (2008) Diagnosis and treatment of Wilson disease: an update. Hepatology 47(6):2089\u20132111","journal-title":"Hepatology"},{"key":"9746_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.biochi.2014.08.017","volume":"106","author":"S Wang","year":"2014","unstructured":"Wang S, Shi N, Geng Z, Li X, Xin Hu, Wang Z (2014) Inhibitory mechanism of dimercaptopropanesulfonic acid (DMPS) in the cellular biomethylation of arsenic. Biochimie 106:167\u2013174","journal-title":"Biochimie"},{"key":"9746_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jphs.2017.05.006","volume":"134","author":"Y Yajima","year":"2017","unstructured":"Yajima Y, Kawaguchi M, Yoshikawa M, Okubo M, Tsukagoshi E, Sato K, Katakura A (2017) The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments. J Pharmacol Sci 134:1\u20138","journal-title":"J Pharmacol Sci"},{"key":"9746_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.crad.2012.12.003","volume":"68","author":"DR Hingwala","year":"2013","unstructured":"Hingwala DR, Kesavadas C, Thomas B, Kapilamoorthy TR (2013) Susceptibility weighted imaging in the evaluation of movement disorders. Clin Radiol 68:338\u2013348","journal-title":"Clin Radiol"},{"key":"9746_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jns.2012.11.009","volume":"325","author":"Y-H Han","year":"2013","unstructured":"Han Y-H, Lee J-H, Kang B-M, Mun C-W, Baik S-K, Shin Y-i et al (2013) Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy. J Neurol Sci 325:29\u201335","journal-title":"J Neurol Sci"},{"key":"9746_CR7","first-page":"171","volume":"37","author":"X Zhou","year":"2011","unstructured":"Zhou X, Li X, Huang W, Liu B, Liang Y, Zhu R et al (2011) (2011) Improved Young scale\u2014a scale for the neural syndrome of Wilson disease. Chin J Nerv Ment Dis 37:171\u2013172","journal-title":"Chin J Nerv Ment Dis"},{"key":"9746_CR8","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1053\/jhep.2003.50252","volume":"37","author":"EA Roberts","year":"2003","unstructured":"Roberts EA, Schilsky MI (2003) Apractice guideline on Wilson disease. Hepatology 37:1475\u20131492","journal-title":"Hepatology"},{"issue":"3","key":"9746_CR9","doi-asserted-by":"publisher","first-page":"E405","DOI":"10.3390\/cancers11030405","volume":"11","author":"Y Eso","year":"2019","unstructured":"Eso Y, Takai A, Takahashi K, Ueda Y, Taura K, Marusawa H, Seno H (2019) Combination of Mac-2 binding protein glycosylation isomer and up-to-seven criteria as a useful predictor for Child\u2013Pugh grade deterioration after transarterial chemoembolization for hepatocellular carcinoma. Cancers (Basel) 11(3):E405","journal-title":"Cancers (Basel)"},{"key":"9746_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.clineuro.2014.09.030","volume":"127","author":"B Bergera","year":"2014","unstructured":"Bergera B, Maderb I, Damjanovicb K, Niesena W-D, Sticha O (2014) Epileptic status immediately after initiation of d-penicillamine therapy in a patient with Wilson\u2019s disease. Clin Neurol Neurosurg 127:122\u2013124","journal-title":"Clin Neurol Neurosurg"},{"key":"9746_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11894-011-0227-3","volume":"14","author":"KH Weiss","year":"2012","unstructured":"Weiss KH, Stremmel W (2012) Evolving perspectives in Wilson disease: diagnosis, treatment and monitoring. Curr Gastroenterol Rep 14:1\u20137","journal-title":"Curr Gastroenterol Rep"},{"key":"9746_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.lab.2005.01.007","volume":"145","author":"M Marcellini","year":"2005","unstructured":"Marcellini M, Di Ciommo V, Callea F (2005) Treatment of Wilson\u2019s disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. Lab Clin Med 145:139\u2013143","journal-title":"Lab Clin Med"},{"issue":"61","key":"9746_CR13","first-page":"166","volume":"52","author":"JJ Pan","year":"2005","unstructured":"Pan JJ, Chu CJ, Chang FY (2005) The clinical experience of Chinese patients with Wilson\u2019s disease. Hepatogastroenterology 52(61):166\u2013169","journal-title":"Hepatogastroenterology"},{"key":"9746_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1478-3231.2010.02354.x","volume":"31","author":"R Bruha","year":"2011","unstructured":"Bruha R, Marecek Z, Pospisilova L et al (2011) Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation. Liver Int 31:83\u201391","journal-title":"Liver Int"},{"key":"9746_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cca.2007.05.005","volume":"383","author":"A Geetha","year":"2007","unstructured":"Geetha A, Jeyachristy SA, Selvamathy SM et al (2007) A study on the concentrations of serum zinc, non-ceruloplasmin copper, reactive oxygen and nitrogen species in children with Wilson's disease. Clin Chim Acta 383:165\u2013167","journal-title":"Clin Chim Acta"},{"issue":"6","key":"9746_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12264-009-0225-8","volume":"25","author":"W Zhang","year":"2009","unstructured":"Zhang W, Sun SG, Jiang YH, Qiao X, Sun X, Wu Y (2009) Determination of brain iron contentin patients with Parkinson\u2019s disease using magnetic susceptibility imaging. Neurosci Bull 25(6):353\u2013360","journal-title":"Neurosci Bull"},{"key":"9746_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.dld.2009.06.012","volume":"42","author":"O Sorbello","year":"2010","unstructured":"Sorbello O, Sini M, Civolani A, Demelia L (2010) HFE gene mutations and Wilson\u2019s disease in Sardinia. Dig Liver Dis 42:216\u2013219","journal-title":"Dig Liver Dis"},{"key":"9746_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.clinimag.2013.02.001","volume":"37","author":"M Rossi","year":"2013","unstructured":"Rossi M, Ruottinen H, Soimakallio S, Elovaara I, Dastidar P (2013) Clinical MRI for iron detection in Parkinson's disease. Clin Imaging 37:631\u2013636","journal-title":"Clin Imaging"},{"key":"9746_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3174\/ajnr.A1461","volume":"30","author":"S Mittal","year":"2009","unstructured":"Mittal S, Wu Z, Neelavalli J, Haacke EM (2009) Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. Am J Neuroradiol 30:232\u2013252","journal-title":"Am J Neuroradiol"},{"key":"9746_CR20","doi-asserted-by":"publisher","first-page":"e01459","DOI":"10.1002\/brb3.1459","volume":"00","author":"X-X Zhou","year":"2019","unstructured":"Zhou X-X, Li X-H, Chen D-B, Chao Wu, Feng Li, Qin H-L, Xiao-Yong Pu, Liang X-L (2019) Injury factors and pathological features of toxic milk mice during different disease stages. Brain Behav 00:e01459. https:\/\/doi.org\/10.1002\/brb3.1459","journal-title":"Brain Behav"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09746-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-020-09746-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09746-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T21:11:06Z","timestamp":1613250666000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-020-09746-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["9746"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-09746-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,14]]},"assertion":[{"value":"4 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or research committee and with the 1964 Helsinki declaration and its amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}